Bactiguard appoints new CFO

Bactiguard Holding AB (publ) has appointed Cecilia Edström, today Senior Vice President Sales and New Business, as acting Chief Financial Officer (CFO). She succeeds Fredrik Järrsten, who will leave Bactiguard to assume a new CFO role in another company. Cecilia Edström will assume her new position on 15 September.

”Fredrik Järrsten has been Bactiguard’s CFO since the spring of 2014. Since then Bactiguard has been through a major transition, which started with the refinancing and IPO in June 2014. The financial infrastructure has been strengthened and the quality of the financial reporting improved, and in this process Fredrik has been instrumental. I would like to thank him for his valuable contribution to Bactiguard and wish him all the best in his new role”, says Christian Kinch, CEO.

“Cecilia Edström is an experienced executive and leader, with strong business focus and broad competence from some of Sweden’s major listed international companies. She has a solid financial background and her experience was a prerequisite for Bactiguard’s IPO. She is already part of Bactiguard’s executive management, with responsibility for new business development and international sales. I am pleased that we, with this solution, safeguard important competence and continuity in Bactiguard and pave the way for an optimal long term solution”, Christian Kinch continues.

Cecilia Edström was previously a member of Group Management at Scania and TeliaSonera. She has a Bachelor of Science from the Stockholm School of Economics and joined the corporate finance team at SEB thereafter. She joined Bactiguard in the spring of 2014, initially with responsibility for communication and IR and to prepare the company for the IPO. As acting CFO, Cecilia Edström will maintain responsibility for new business development and Fredrik Järrsten will remain in the company a short period of time to ensure a smooth transition.

This information is information that Bactiguard Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below 2017-08-28, at. 08.00

For further information, please contact:

Christian Kinch, CEO, tel: +46 8 440 58 80

Cecilia Edström, mobile: +46 72 226 23 28

About Bactiguard
Bactiguard is a Swedish medtech company with a mission of preventing healthcare associated infections, reducing the use of antibiotics and saving lives by developing and supplying infection prevention solutions for the healthcare industry. The company’s patented coating prevents healthcare associated infections by reducing bacterial adhesion and growth on medical devices. Bactiguard®-coated urinary catheters are market leading in the US and Japan, and in recent years the company has developed its own product portfolio of catheters for the urinary and respiratory tract and the blood stream. Bactiguard is currently in a strong expansion phase, focused on new markets in the Europe, Middle East, Asia, South America and Southern Africa. The company has market presence in some 50 countries and has about 60 employees. Its headquarters is located in Stockholm and production facilities in Sweden and Malaysia. Bactiguard is listed on Nasdaq Stockholm. Read more about Bactiguard at www.bactiguard.com

About Us

Bactiguard is a Swedish medtech company with a global presence, offering a solution that prevents healthcare associated infections caused by medical devices. By preventing infections, we contribute to a reduced use of antibiotics and the spread of multi-resistant bacteria, which is a growing problem worldwide. We save lives, increase patient safety and significantly reduce the cost for the healthcare and society. Our technology is well-proven, safe and tissue friendly and consist of a thin layer of noble metals that prevents bacterial growth. The coating can be applied on almost all medical devices. Bactiguard-coated urinary catheters are market leading in the US and Japan and the company has also its own product portfolio consisting of foley catheters, central venous catheters and endotrachealtubes. Bactiguard is a growth company, focused on markets in Europe, Middle East, Asia and Latin America. The company has about 70 employees worldwide, mainly at the headquarters in Stockholm and the production facility in Malaysia and is listed on Nasdaq Stockholm. Read more about Bactiguard at www.bactiguard.com